Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Joseph McCune

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|November 25, 2005
Mycophenolate mofetil for lupus nephritisW Joseph McCune
Current Opinion in Rheumatology|March 20, 2021
Editorial: Quinacrine: au Revoir or Adieu? This safe and effective drug should be reintroducedW Joseph McCune
Current Opinion in Rheumatology|March 18, 2017
Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitisOra Singer, W Joseph McCune
Current Opinion in Rheumatology|March 29, 2019
Treatment of primary and secondary immune thrombocytopeniaRuba Kado, W Joseph McCune
Seminars in Respiratory and Critical Care Medicine|September 4, 2007
Advances in immunosuppressive therapyWendy Marder, W Joseph McCune
Current Opinion in Rheumatology|July 15, 2024
SGLT-2 inhibitors: new horizons for rheumatologistsKatherine Chakrabarti, W Joseph McCune
Current Opinion in Rheumatology|April 20, 2022
Advances in the clinical use of hydroxychloroquine levelsKatherine Chakrabarti, W Joseph McCune
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 24, 2019
Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosusRuba Kado, W Joseph McCune
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Advances in immunosuppressive drug therapy for use in autoimmune disease and systemic vasculitisWendy Marder, W Joseph McCune
Current Opinion in Rheumatology|March 21, 2023
Glucocorticoid-induced osteoporosis in premenopausal women: management for the rheumatologistKatherine Chakrabarti, W Joseph McCune
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|November 25, 2005
Mycophenolate mofetil for lupus nephritisW Joseph McCune
Current Opinion in Rheumatology|March 20, 2021
Editorial: Quinacrine: au Revoir or Adieu? This safe and effective drug should be reintroducedW Joseph McCune
Current Opinion in Rheumatology|March 18, 2017
Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitisOra Singer, W Joseph McCune
Current Opinion in Rheumatology|March 29, 2019
Treatment of primary and secondary immune thrombocytopeniaRuba Kado, W Joseph McCune
Seminars in Respiratory and Critical Care Medicine|September 4, 2007
Advances in immunosuppressive therapyWendy Marder, W Joseph McCune
Current Opinion in Rheumatology|July 15, 2024
SGLT-2 inhibitors: new horizons for rheumatologistsKatherine Chakrabarti, W Joseph McCune
Current Opinion in Rheumatology|April 20, 2022
Advances in the clinical use of hydroxychloroquine levelsKatherine Chakrabarti, W Joseph McCune
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 24, 2019
Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosusRuba Kado, W Joseph McCune
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Advances in immunosuppressive drug therapy for use in autoimmune disease and systemic vasculitisWendy Marder, W Joseph McCune
Current Opinion in Rheumatology|March 21, 2023
Glucocorticoid-induced osteoporosis in premenopausal women: management for the rheumatologistKatherine Chakrabarti, W Joseph McCune
Pageof 9